Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Phosphatidylserine, Taurine, and Caffeine for Cognitive Fatigue in Professional Football Players (TCPS-Foot)

9 luglio 2026 aggiornato da: Krzysztof Mizera, Vizja University in Warsaw

Neurocognitive Fatigue Resistance, Visual Search Efficiency, and Tactical Decision-Making After Phosphatidylserine-Containing Taurine-Caffeine Supplementation in Professional Male Football Players

This randomized, double-blind, placebo-controlled, parallel-group trial will evaluate the effects of 14 days of taurine-caffeine supplementation with or without phosphatidylserine on neurocognitive fatigue resistance, visual search efficiency, and football-specific tactical decision-making in professional male football players. Sixty-two male outfield football players from two professional clubs will be randomized to placebo, taurine plus caffeine, or taurine plus caffeine plus phosphatidylserine. Laboratory and field-based outcomes will be assessed at baseline and after the supplementation period.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

This study is designed to determine whether adding phosphatidylserine to a taurine-caffeine supplementation strategy supports attentional control, efficient visual search, and accurate tactical decision-making under acute neurocognitive load in professional male football players.

Participants will complete familiarization, baseline laboratory testing, baseline field testing, 14 days of supplementation, post-intervention laboratory testing, and post-intervention field testing. The laboratory protocol will include a high-load Stroop/Flanker task followed by a football-specific video decision-making task with screen-based eye-tracking. The video task will include offensive and transitional football situations requiring players to select the most appropriate tactical option under time pressure. Some clips will require inhibition of an immediately attractive but suboptimal forward action.

The primary outcome will be the change in tactical inhibitory decision accuracy under neurocognitive load from baseline to post-intervention. Secondary outcomes will include overall decision accuracy, decision time, impulsive tactical errors, mental fatigue, Stroop/Flanker reaction-time variability, time to first fixation on the optimal option, dwell time on the optimal option, situational awareness accuracy, and field-based reactive passing decision performance. Field-based transfer will be assessed using a Reactive Passing Decision Test, the Loughborough Soccer Passing Test, and standardized small-sided games.

Tipo di studio

Interventistico

Iscrizione (Stimato)

62

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

  • Polonia
      • Lodz, Polonia
        • Professional Football Training Center
        • Contatto:
      • Warsaw, Polonia
        • Professional Football Training Center
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  • Male professional outfield football players aged 18 to 37 years.
  • First-team players or selected U19 players aged 18 years or older who are regularly integrated into first-team training.
  • Regular participation in club training.
  • At least 5 years of systematic football training experience.
  • Free from injury or illness limiting full participation in training and testing.
  • Normal or corrected-to-normal vision.
  • Ability to complete the laboratory and field-based testing procedures.
  • Written informed consent provided before participation.

Exclusion Criteria:

  • Goalkeepers.
  • Current injury or illness limiting full participation in testing.
  • Neurological disease.
  • Recent concussion or head trauma.
  • Uncorrected visual impairment.
  • Use of phosphatidylserine, nootropic agents, or strong stimulants during the previous 4 weeks.
  • Non-standard caffeine intake on testing days.
  • Failure to comply with pre-test standardization procedures.
  • Failed eye-tracker calibration.
  • Loss of more than 30% of gaze data during the football-specific decision-making task.
  • Withdrawal of consent.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Quadruplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore placebo: Placebo
Participants randomized to this arm will receive an inert placebo for 14 days. The placebo will be provided in identical coded packs matched for appearance, number of units, and packaging with the active supplements.
Integratore alimentare: Placebo
Inert placebo matched with the active supplements for appearance, number of units, and packaging. The placebo will be administered for 14 days.
Comparatore attivo: Taurine Plus Caffeine
Participants randomized to this arm will receive taurine 1500 mg/day plus caffeine 200 mg/day for 14 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.
Integratore alimentare: Taurine Plus Caffeine
Taurine 1500 mg/day plus caffeine 200 mg/day administered for 14 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.
Sperimentale: Taurine, Caffeine, and Phosphatidylserine
Participants randomized to this arm will receive taurine 1500 mg/day plus caffeine 200 mg/day plus phosphatidylserine 600 mg/day for 14 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.
Integratore alimentare: Taurine, Caffeine, and Phosphatidylserine
Taurine 1500 mg/day plus caffeine 200 mg/day plus phosphatidylserine 600 mg/day administered for 14 days. On training and testing days, the supplement will be consumed approximately 60 minutes before the main training session or testing procedure. On non-training days, it will be consumed at a consistent morning time.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Tactical Inhibitory Decision Accuracy Under Neurocognitive Load
Lasso di tempo: Baseline and 14 days of supplementation
Tactical inhibitory decision accuracy will be assessed using football-specific video clips requiring inhibition of an immediately attractive but suboptimal tactical action. Responses will be scored as 1 point for an optimal decision, 0.5 points for an acceptable decision, and 0 points for an incorrect decision. The outcome will be calculated as the mean score across inhibitory tactical clips. The score ranges from 0 to 1, with higher values indicating better tactical inhibitory decision accuracy.
Baseline and 14 days of supplementation

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Overall Football-Specific Decision Accuracy
Lasso di tempo: Baseline and 14 days of supplementation
Overall football-specific decision accuracy will be assessed using video-based offensive and transitional football situations. Players will select the most appropriate tactical option under time pressure. The outcome will be expressed as the percentage of correct or expert-rated optimal decisions, with higher values indicating better decision-making accuracy.
Baseline and 14 days of supplementation
Change in Football-Specific Decision Time
Lasso di tempo: Baseline and 14 days of supplementation
Decision time will be assessed during the football-specific video decision-making task. It will be measured as the time taken to select a tactical response after the critical decision point. The outcome will be expressed in milliseconds, with lower values indicating faster decision-making.
Baseline and 14 days of supplementation
Change in Impulsive Tactical Errors
Lasso di tempo: Baseline and 14 days of supplementation
Impulsive tactical errors will be assessed during football-specific video clips. These errors will include selections of immediately attractive but suboptimal tactical options, such as inappropriate forward actions, low-quality shots, or forced progressive decisions when a safer or more appropriate option is available.
Baseline and 14 days of supplementation
Change in Stroop/Flanker Reaction-Time Variability
Lasso di tempo: Baseline and 14 days of supplementation
Reaction-time variability will be assessed during the high-load Stroop/Flanker task used to induce neurocognitive load. The task will assess attentional control, response inhibition, conflict monitoring, and reaction-time stability. The outcome will be expressed in milliseconds.
Baseline and 14 days of supplementation
Change in Post-Task Mental Fatigue
Lasso di tempo: Baseline and 14 days of supplementation
Mental fatigue will be assessed immediately after the neurocognitive load task using a visual analogue scale. The scale will range from 0 to 10, with higher scores indicating greater perceived mental fatigue.
Baseline and 14 days of supplementation
Change in Time to First Fixation on the Optimal Tactical Option
Lasso di tempo: Baseline and 14 days of supplementation
Time to first fixation on the optimal tactical option will be assessed using screen-based eye-tracking during the football-specific video decision-making task. The outcome will be expressed in milliseconds and will reflect how quickly the player visually orients toward the expert-defined optimal option.
Baseline and 14 days of supplementation
Change in Dwell Time on the Optimal Tactical Option
Lasso di tempo: Baseline and 14 days of supplementation
Dwell time on the optimal tactical option will be assessed using screen-based eye-tracking during the football-specific video decision-making task. The outcome will be expressed as the percentage of total viewing time spent fixating on the expert-defined optimal tactical option.
Baseline and 14 days of supplementation
Change in Situational Awareness Accuracy
Lasso di tempo: Baseline and 14 days of supplementation
Situational awareness accuracy will be assessed using probes presented after selected football-specific video clips. These probes will evaluate whether players correctly identified key tactical information, including available space, pressure location, number of defenders, teammate positioning, and defensive-line configuration.
Baseline and 14 days of supplementation
Change in Reactive Passing Decision Test Accuracy
Lasso di tempo: Baseline and 14 days of supplementation
Reactive Passing Decision Test accuracy will be assessed during a field-based football-specific task. Players will dribble into a decision zone and respond to a late visual or situational cue by selecting and executing the optimal passing option. The outcome will be expressed as the percentage of accurate decisions.
Baseline and 14 days of supplementation

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Vizja University in Warsaw

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 luglio 2026

Completamento primario (Stimato)

1 luglio 2026

Completamento dello studio (Stimato)

1 agosto 2026

Date di iscrizione allo studio

Primo inviato

5 luglio 2026

Primo inviato che soddisfa i criteri di controllo qualità

5 luglio 2026

Primo Inserito (Effettivo)

10 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

9 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • MIZERA -4-TCPS-FOOT-2026

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

No individual participant data will be shared because the study includes a small sample of professional football players from a limited number of clubs, which may increase the risk of indirect participant identification. Only aggregated and anonymized study results will be reported.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Stanchezza mentale

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Tunisia

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

Sottoscrivi